Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger ...
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger ...
Source: pr-inside.com
Accelerated Approval Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Accelerated Approval Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Accelerated Approval Program Today - Breaking & Trending Today
Eli Lilly (LLY) Q4 2023 Earnings Call Transcript
LLY earnings call for the period ending December 31, 2023.
Source: yahoo.com
European Commission Approves Pfizer's ELREXFIO® for Relapsed and Refractory Multiple Myeloma -December 08, 2023 at 07:56 am EST
Conditional marketing authorization is based on clinically meaningful response rates, duration of response, and safety from the Phase 2 MagnetisMM-3 trial ELREXFIO is an off-the-shelf ,...
Source: marketscreener.com
European Commission Approves Pfizer's ELREXFIO for Relapsed and Refractory Multiple Myeloma
08.12.2023 - Pfizer Inc. (NYSE:PFE) today announced the European Commission (EC) has granted conditional marketing authorization for ELREXFIO (elranatamab). ELREFXIO is a targeted immunotherapy for the treatment of adult patients with relapsed and refractory ...
Source: wallstreet-online.de
CMMI Issues Report on Status of Pending Drug Models | Manatt, Phelps & Phillips, LLP
The Center for Medicare and Medicaid Innovation (CMMI) has provided new updates on CMS’ planned initiatives to address prescription drug costs in a blog post from Director Liz Fowler....
Source: jdsupra.com